11 Einträge gefunden

1. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin

   1. Dyshlovoy, Sergey A
   2. Otte, Katharina
   3. Venz, Simone
   4. Hauschild, Jessica
   5. Junker, Heike
   6. Makarieva, Tatyana N
   7. Balabanov, Stefan

   2017 - Forschungsinformationssystem des UKE
2. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers

   1. Ummanni, Ramesh
   2. Duscharla, Divya
   3. Barett, Christine
   4. Venz, Simone
   5. Schlomm, Thorsten
   6. Heinzer, Hans
   7. Walther, Reinhard

   2015 - Forschungsinformationssystem des UKE
3. Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer

   1. Dyshlovoy, Sergey A
   2. Venz, Simone
   3. Shubina, Larisa K
   4. Fedorov, Sergey N
   5. Walther, Reinhard
   6. Jacobsen, Christine
   7. Stonik, Valentin A

   2014 - Forschungsinformationssystem des UKE
4. Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors

   1. Balabanov, Stefan
   2. Wilhelm, Thomas
   3. Venz, Simone
   4. Amsberg, Gunhild
   5. Scharf, Christian
   6. Pospisil, Heike
   7. Balabanov, Melanie

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
5. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

   1. Preukschas, Michael
   2. Hagel, Christian
   3. Schulte, Alexander
   4. Riecken, Kristoffer
   5. Lamszus, Katrin
   6. Sievert, Henning
   7. Pällmann, Nora

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
6. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

   1. Minner, Sarah Jane Pauline
   2. Wittmer, Corinna
   3. Graefen, Markus
   4. Salomon, Georg
   5. Steuber, Thomas
   6. Haese, Alexander
   7. Huland, Hartwig

   2011 - Forschungsinformationssystem des UKE
7. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

   1. Balabanov, Stefan
   2. Gontarewicz, Artur
   3. von Amsberg, Gunhild
   4. Raddrizzani, Laura
   5. Balabanov, Melanie
   6. Bosotti, Roberta
   7. Moll, Jürgen

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
8. Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.

   1. Glaesener, Stephanie
   2. Honecker, Friedemann
   3. Veltman, Imke M
   4. Gillis, Ad J M
   5. Rohlfing, Tina
   6. Streichert, Thomas
   7. Otto, Benjamin

   2008 - Forschungsinformationssystem des UKE
9. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Panse, Jens
   5. Schafhausen, Philippe
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2008 - Forschungsinformationssystem des UKE
10. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

    1. Gontarewicz, Artur
    2. Balabanov, Stefan
    3. von Amsberg, Gunhild
    4. Colombo, Riccardo
    5. Graziano, Alessio
    6. Pesenti, Enrico
    7. Benten, Daniel

    2008 - Forschungsinformationssystem des UKE
11. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.

    1. Mueller, Sandra
    2. Hartmann, Ulrike
    3. Mayer, Frank
    4. Balabanov, Stefan
    5. Hartmann, Joerg T
    6. Brümmendorf, Tim
    7. Bokemeyer, Carsten

    2007 - Forschungsinformationssystem des UKE